1.Cummings SR, Nevitt MC, Browner WS et al Risk factors for hip fracture in white women. N Engl J Med 1995;332:767-773.
2.Kanis JA, Melton LJ, Christiansen C, Johnston CC, Khaltaev N. The diagnosis of osteoporosis. J Bone Min Res 1994;9:1137-1141.
3.Melton LJ, Chrischilles EA, Cooper C. Perspective: How many women have osteoporosis? J Bone Min Res 1992; 7: 1005-1010.
4.Seeley DG, Browner WS, Nevitt MC. Which fractures are associated with low appendicular bone mass in elderly women?The Study of Osteoporotic Fractures. Ann Intern Med 1991; 115:837-842.
5.Kanis JA. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. Osteoporosis Int 1994; 4: 368-371.
6.Eliffors I, Allander E, Kanis JAS. The variable incidence of hip fracture in southern Europe: The Medos Study. Osteoporosis Int; 1994: 4: 253-261.
7.Cooper C, Campion G, Melton LJ. Hip fractures in the elderly: a world wide projection. Osteoporosis Int 1992; 2: 285-289.
8.European Commision: Report on Osteoporosis in the European Community-Action for Prevention. Brussels; European Commission 1998.
9.DeLaet CEDH, Pols HAP. Fractures in the elderly: epidemiology and demography. Bailliere's Clin Endocrinol Metab 2000; 14: 171-179.
10.Ross PD. Clinical Consequences of vertebral fractures. Am J Med 1997; 103: 425-435.
11.O Neill TW, Felsenberg D, Varlow J. The prevalence of vertebral deformity in European men and women: the European Vertebral Osteoporosis Study. J Bone Min Res 1996; 11: 1010-1018.
12.Marshall D, Johnell O, and Wedel H. Meta-analysis of how well measures on bone mineral density predict occurrence of osteoporotic fractures. Br Med J 1996; 312: 1254-1259.
13. Stewart A, Walker LG, Potter RW, Primrose WR, Reid DM. Prediction of a second hip fracture: the potential role of DXA, ultrasound, and other risk factors for targeting of preventative therapy. J Clin Densitometry 1999;2:
14. Tinetti ME, Speechely M, Gunter SF. Risk factors for falls among elderly persons living in the community. N Engl J Med 19888;319:1701-1707
15. Miller PD. Guidelines for the clinical utilization of bone mass measurements in the adult population. Calcif Tiss Int 1995;57:252-252.
16.Riggs BL, Wahner HW, Seeman E. Changes in bone mineral density of the proximal femur and spine with aging: differences between the postmenopausal and senile osteoporosis syndromes. J Clin Invest 1982;70:716-723.
16a. Boutroy S, Bouxsein ML, Munoz F, Delmas PD. In vivo assessment of trabecular bone architecture by high resolution peripheral quantitative CT. J Clin endocrinol metab 2005 90:6508-15.
17. Lian JB and Stein GS. The Cells of Bone in Principles of Bone and Cartilage Metabolism. Ed by Seibel MJ, Robbins S and Bilezikian JP. Academic Press, San Diego 1999 pp 165-185
18. Lorenzo JA and Raisz LG. Cytokines and Prostaglandins in Principles of Bone and Cartilage Metabolism Ed by Seibel MJ, Robbins S and Bilezikian JP. Academic Press San Diego CA 1999 pp 97-109.
19.Udagawa N,Takahashi N, Jimi E, Matsuzaki K, Tsurukai T, Itoh K, Nakagawa N et al Osteoblasts/Stromal Cells Stimulate Osteoclast Differentiation factor/RANKL but not Macrophage Colony Stimulating Factor. Bone 1999; 25:517-523.
20.Emery JG, McDonnell P, Burke MB, Deen KC, Lyn S, Silverman C Dul E, Appelbaum ER, et al Osteoprotegrin is a receptor for the cytotoxic ligand TRAIL J Biol Chem 1998;273:14363-14367.
21.Suda T, Takahashi N and Martin TJ. Modulation of osteoclast differentiation. Endocrine Rev 1992;12:66-80.

22.Li, X. et al. Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis. J Bone Miner Res 24, 578-88 (2009).
23.Ellies, D. L. et al. Bone density ligand, Sclerostin, directly interacts with LRP5 but not LRP5G171V to modulate Wnt activity. J Bone Miner Res 21, 1738-49 (2006).
24.Eghbali-Fatourechi, G. et al. Role of RANK ligand in mediating increased bone resorption in early postmenopausal women. J Clin Invest 111, 1221-30 (2003).
25.Cummings, S. R. et al. Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med 361, 756-65 (2009).

26.Ducy P, Zhang R R, Geoffroy V, Ridall AL, and Karsenty G. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 1997; 89:747-754.
27.Rosen CJ. Growth hormone, IGF-I and the elderly: Clues to potential therapeutic intervention. Endocrine; 1997 7:39-40.

28.Baron, R. & Rawadi, G. Targeting the Wnt/beta-catenin pathway to regulate bone formation in the adult skeleton. Endocrinology 148, 2635-43 (2007).
29.Poole, K. E. et al. Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation. Faseb J 19, 1842-4 (2005).

30.Albright F. Postmenopausal osteoporosis. JAMA 1941; 116 2465-2474.
31.Chestnust C,Notelovitz M, Clark G, Drinkwater B, Rosen C,Bell N, English S, Johnston CC, Cain D,Flessland K, Mallinak N. Use of the N-telopeptide of type I collagen to monitor the effect of therapy and predict changes in bone mineral density in postmenopausal women treated with hormone replacement therapy. Am J Med;1997:102:29-37.
32.Ettinger B, Pressman A, Sklarin P, Bauer D Cualey JA and Cummings SR. Associations between low levels of serum estradiol, bone density and fractures among elderly women: SOF. J Clin Endocrinol Metab 1998;83:2239-2243.
33.Greendale GA, Edelstein S Barrett-Connor E. Endogenous sex steroids and bone mineral density in older women and men. J Bone Miner Res 1997;12:1833-1837.
34.Smith EP, Boyd J, Frank GR, Takahasi H, Cohen RM, Specker B, Williams TC, Lubahn DB, Korach KS. Estrogen resistance caused by a mutation in the estrogen receptor gene in a man. N Engl J Med 1994;331:1056-1061.
35.Morishima A, Grumbach MM, Simpson ER, Fisher C, Qin K. Aromatase deficiency in male and female siblings cuased by a novel mutation in the physiological role of estrogens. J Clin Endocrinol Metab 1995;3689-3698.
36.Carani C, Qin K, simoni M, Faustini-Faustini S, Boyd J, Korach KS, Simpson ER. Effect of testosterone and estradiol in a man with aromatase deficiency. N Engl J Med 1997; 337:91-95.
37.Jilka RG, Girsole GH, Passeri G, Williams D, Abrams J, Boyce B, Broxmeyer H and Manoloagas S. Increased osteoclast development after estrogen loss: mediation by IL-6. Science 1992;257:88-91.
38.Pacifici R, Brown C, Puscheck E. The effect of surgical menopause and estrogen replacement on cytokine release from human blood monocytes. Proc Natl Acad Sci USA 1991;88:5134-5138.
39.Manolagas SC, Jilka RL Emerging insights into the pathophysiology of osteoporosis. N Engl J Med 1995;332:305-311.
40.Snyder PJ, Peachey H, Hannoush P, Berlin JA, Loh L, Lenrow DA, Holmes JH, Diewati A, santana J, Rosen CJ and Strom BL. Effect of testosterone treatment on body composition and muscle strength in men over 65.J Clin Endo Metab 1999;84:2647-2653.
41.Dresner-Pollak R, Parker RA, Poku M, Thompson J Seibel MJ, Greenspan SL. Biochemical markers of bone turnover reflect femoral bone loss in elderly women. Clacif Tissue Int 1996:59:328-333.
42.Food and Nutrition Board Institute of Medicine 2011; Dietary Reference Intakes for Calcium, Phosphorus, Magnesium Vitamin D and Fluoride. Washington DC, National Academy Press. www.iom/vitaminD.edu
43.Storm D, Smith-Porter E,Musgrave KO, Vereault D, Patton C, Kessenich CR, Eslin R, Mohan S, Chen T, Holick MF and Rosen CJ. Calcium supplementaiton prevents seasonal bone loss and changes in biochemical markers of bone turnover in elderly New England women: A Randomized Placebo-Controlled Trial. J Clin Endocrinol Metab 1998;83;3817-3826
44.Rosen CJ Morrison A, Zhou H, Storm D, Hunter S, Musgrave KO, Chen T, et al. Elderly women in northern new England exhibit seasonal changes in bone mineral density and calciotropic hormones. Bone Miner 1994;25:83-92.
45.LeBoff MS, Kohlmeier L, Hurwitz S, Franklin J, Wright J Glowacki J. Occult vitmain D deficiency in postmenopausal US women with acute hip fracture. JAMA 1999; 282:1505-1511.
46.Rosen C, Donahue LR, Hunter S, Holick M, Kavookjian H,Kirshenbaum A, Mohan S and Baylink DJ. The 24/25kD serum insulin-like growth factor binding protein is increased in elderly women with fractures. J Clin Endocrinol Metab. 1992;74:24-28.
47.Heaney RP, McCarron DA, Dawson Hughes B, Oparil S, Berga SL, Stern JS, Barr SI, Rosen CJ. Dietary Changes favorably affect bone remodeling in older adults. JADA:99:99:1228-1233.
48.Cushing H. Basophile adenomas of the pituitary body and their clinical manifestations. Bull Johns Hopkins Hop 1932;50:137-145.
49.Thacker H. Glucorticoid-induced Osteoporosis. Cleveland Clinic J Med 2010 77 843-844.
 50.Teegarden D, Proulx WR, martin BR. Peak bone mass in young women. J Bone Miner Res 1995;10:711-715.
51.Prior JC, Vigna Y, Schechter MT, Burgess AE. Spinal bone loss and ovulatory disturbances. N Engl J Med 1990;323:1221-1227.
52.Gilsanz V, Loro ML,Roe TF,Syrre J, Gilsanz R and Schulz EE. Gender differences in vertebral size in adutls: biomechanical implications. J clin Invest 1995;95:2332-2337.
53.Bachrach LK, Guido D, Katzman D, Litt IF, Marcus R. Decreased bone density in adolescent girls with anorexia nervosa. Pediatrics 19900;86:440-447.
54.Johnston CC, Miller JZ, Slemenda CW, Reister TK, Hui S, Christian JC, Peacock M. Calcium supplementation and icnreases in bone mineral density in children. N Engl J Med 1992; 327 82-87.
60.Menaa C, Vrtovsnik F, Freidlander G,Corvol M and Garbedian M. IGF-I a unque calcium dependent stimulator of 1,25 vitamin D production. J Biol Chem 1995;270:25461-25467.
55.McKay HA, Bailey DA, Wilkinson AA, Houston CS. Familial comparison of bone mineral density at the proximal femur and lumbar spine. Bone Miner 1994;24:95-107.
56.Smith DM, Nance WE, Kang KW, Christian JC, Johnston CC. Genetic factors in determining bone mass. J Clin Invest 1973; 52:2800-2808.
57.Seeman E. Genetic Determinants of the Population Variance in Bone Mineral Density. In The Aging Skeleton eds by CJ Rosen, J Glowacki and JP Bilezikian 1999; Academic Press San Diego, CA pp77-84.
58.Rogers J, Mahaney MC, Beamer WG, Donahue LR and Rosen CJ. Beyond one gene-one disease: Alternative strategies for decifering genetic determinants of osteoporosis Calcif Tiss Int 1997;60:225-228.
59.Utterlinden AG, Burger H, Huang Q, Fang Y, MCGuigan FEA, Grant SFA, Hofman A et al. Relation of alleles of the collagen type I alpha 1 gene to bone density and the risk of osteoporotic fractures in postmenopausal women. N Engl J med 1998;338:1016-1021.
60.Boyden LM, Mao J, Belsky J, et al. High bone density due to mutation in LDL-receptor related protein-5.  N Eng Jour Med 346:   , 2002
61.Bonjour JP, Carrie AL, Ferrari S. Calcium enriched foods and bone mass growth in prepurbertal girls: a randomized double blind placebo controlled trial. J Clin Invest 1997 99:1287-1294.
62.CadoganJ, Blumsehn A, Barker M, Eastell R. A longitudinal study of bone gain in pubertal girls: anthropometric and biochemical correlates. J Bone Min Res 1998;13:1602-1612.
63.Weaver CM, Peacock M and Johnston CC. Adolescent nutrition in the prevention of postmenopausal osteoporosis. J Clin Endocrinol Metab;1999: 84:1839-1843.